FINANCIAL NEWS
Untitled Page
Edwards Lifesciences launches $500 million share repurchase program
Irvine-based firm's board of directors approved the measure last week.
By Kristen SchottPublished: February 15, 2010 01:48 PM
Irvine-based medical device maker Edwards Lifesciences Corp. is moving forward with its $500 million share repurchase program.
The platform was approved last week by the firm's board of directors, and speaks to their belief in the company's future initiatives, according to Edwards Lifesciences CEO and Chairman Michael Mussallem.
"This new program reaffirms the confidence we have in our long-term growth prospects, and provides us with an opportunity to continue returning value to shareholders," he says.
The company is also in the process of completing its current $250 million share repurchase program. The measure was approved in 2008, and is expected to come to a close early this year.
NEXT PAGE >>
Related headlines
Aliso Viejo-based Clarient introduces lung cancer test
Irvine-based Quality Systems acquires Opus Healthcare
Santa Ana's Ingram Micro teams with NextGen Healthcare
|
||||
|
The platform was approved last week by the firm's board of directors, and speaks to their belief in the company's future initiatives, according to Edwards Lifesciences CEO and Chairman Michael Mussallem. "This new program reaffirms the confidence we have in our long-term growth prospects, and provides us with an opportunity to continue returning value to shareholders," he says. The company is also in the process of completing its current $250 million share repurchase program. The measure was approved in 2008, and is expected to come to a close early this year. NEXT PAGE >> Related headlines Aliso Viejo-based Clarient introduces lung cancer test Irvine-based Quality Systems acquires Opus Healthcare Santa Ana's Ingram Micro teams with NextGen Healthcare |
||||
